IL-1 beta Protein
Quick Overview for IL-1 beta Protein (ABIN7849736)
Target
See all IL-1 beta (IL1B) ProteinsProtein Type
Origin
Source
Application
Purity
-
-
Purpose
- Recombinant Human Interleukin-1beta, IL1B Protein
-
Endotoxin Level
- < 0.1 ng/μg (1 EU/μg) by LAL test
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Buffer
- Lyophilized,Each vial contains 10 mM Phosphate bufferand 200 mM NaCl( pH 7.0) without preservatives.
-
Preservative
- Without preservative
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Ship at 4°C. Upon receipt,store at -20°C for long term. Avoid repeated freeze and thaw cycles.
-
-
- IL-1 beta (IL1B) (Interleukin 1, beta (IL1B))
-
Alternative Name
- IL1B
-
Background
-
Synonyms: Interleukin-1 beta, IL1B, IL-1 beta, Catabolin, IL1F2, IL-1B, IL-1, IL1-BETA, IL1F2, interleukin 1 beta.
Description: Recombinant human IL-1 beta protein.
Background: Interleukin-1β (IL-1β) is a potent stimulator of bone resorption whose gene is mapped to 2q14, and has been implicated in the pathogenesis of high bone turnover and osteoporosis. It can reset glucose homeostasis at central levels. It cause oligodendrocyte death in coculture with astrocytes and microglia, and also can cause nuclear export of a specific NCOR corepressor complex, resulting in derepression of a specific subset of nuclear factor-kappa-B (NFKB)-regulated genes. Pathak et al. (2011) proposed that IL1B blockade may be a viable therapy for patients with autoimmune inner ear disease or sensorineural hearing loss that fail to respond to corticosteroids.
-
Pathways
- NF-kappaB Signaling, Interferon-gamma Pathway, TLR Signaling, Negative Regulation of Hormone Secretion, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Glycosaminoglycan Metabolic Process, Myometrial Relaxation and Contraction, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Autophagy, Cancer Immune Checkpoints, Inflammasome
Target
-